chenodeoxycholic acid has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Fujita, K; Iguchi, Y; Imura, J; Nishida, T; Nishikawa, M; Ueda, H; Une, M; Watanabe, S | 1 |
| Carino, A; Cipriani, S; D'Amore, C; Distrutti, E; Fiorucci, S; Mencarelli, A; Renga, B; Sepe, V; Zampella, A | 1 |
2 other study(ies) available for chenodeoxycholic acid and Colitis
| Article | Year |
|---|---|
Hyodeoxycholic Acid (HDCA) Prevents Development of Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice: Possible Role of Synergism between DSS and HDCA in Increasing Fecal Bile Acid Levels.
Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Colitis; Deoxycholic Acid; Dextran Sulfate; Mice; Receptors, G-Protein-Coupled | 2022 |
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chenodeoxycholic Acid; Chromatin; Colitis; Dexamethasone; Humans; Mice; Mice, Knockout; Mifepristone; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Receptors, Glucocorticoid; Response Elements; Trinitrobenzenesulfonic Acid | 2013 |